Market Overview:
The Global GI Stool Testing Market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of gastrointestinal diseases, rising awareness about early diagnosis and treatment of gastrointestinal diseases, and technological advancements in stool testing methods. Based on type, the global GI stool testing market is segmented into microscopy tests, ova & parasites test, occult blood test, stool biomarkers tests, and others. The microscopy tests segment is expected to account for the largest share of the global GI stool testing market in 2018. This segment includes various microscopic examination techniques such as direct smears or wet mounts for detection of parasites; concentration techniques such as sedimentation or flotation for detection of eggs or larvae; Gram staining for bacteria identification; and immunofluorescence assay (IFA) for detecting viral antigens in feces samples. The ova & parasites test segment is projected to grow at the highest CAGR during the forecast period owing to increasing prevalence of parasitic infections across the globe. Based on application, hospitals accounted for majority share of revenue generated by GI stool testing market in 2017 followed by diagnostics centers and laboratories and research centers.
Product Definition:
GI stool testing is a diagnostic procedure that helps to identify the presence of abnormalities in the gastrointestinal tract. The test may be used to help diagnose conditions such as Crohn's disease, ulcerative colitis, and cancerous tumors.
Microscopy Tests:
Microscopy tests are used for the detection of diseases in the small intestine. These tests are also known as endoscopic mucosal probes, and they can be performed during an endoscopy or any other time after a scopic examination of the gastrointestinal tract. The most common use of these procedures is to detect gastric ulcers but it also has applications in diagnosis such as Crohn's disease, celiac disease, intestinal inflammation and cancer among others.
Ova & Parasites Test:
Ova and parasites test is used for the detection of ova and parasites in the stool sample. It helps to diagnose parasitic infection, gastrointestinal (GI) disease, or other medical problem. This test is also useful for monitoring diseases such as diarrhea or intestinal parasitism.
The global ova & parasites test market was estimated at USD 498 million in 2014.
Application Insights:
Based on application, the global market is segmented into hospitals, diagnostics centers and laboratories, research centers and academic institutions. Hospitals held the largest share in 2017 owing to increasing prevalence of infectious diseases that demand stool tests for diagnosis. Diagnostic Centers and Laboratories are anticipated to witness lucrative growth over the forecast period due to rising number of patients with gastrointestinal disorders requiring investigation. Research Centers and Academic Institutes are expected to witness significant growth during the forecast period owing to increase government funding for research related GI stools testing applications.
Regional Analysis:
Asia Pacific dominated the global market in 2017. This can be attributed to increasing prevalence of infectious diseases, rising number of road accidents and chronic diseases, such as cancer and diabetes. In addition, growing awareness about giardia lamblia infection among children is anticipated to drive the regional market over the forecast period.
The Asia Pacific region is expected to witness a CAGR of XX% during the forecast period owing to factors such as changing lifestyle and increase in chronic disease burden due to urbanization & globalization that has leded increased mobility between countries thus increasing risk for exposure with infected people or animals thereby leading transmission of infections (2). The Middle East & Africa region is projecteded grow at a lucrative rate over this period due its high unmet diagnostic needs coupled with low cost-to-diagnose ratio thus making it an attractive investment destination for players operating in this space (3). These aforementioned factors are anticipated contribute toward growth rate observed during the forecast period.
Growth Factors:
- Increasing incidence of gastrointestinal diseases: The incidence of gastrointestinal diseases is increasing globally, which is expected to boost the demand for GI stool testing. For instance, according to the World Health Organization (WHO), in 2015, there were 1.3 billion cases of diarrhea and 495,000 deaths due to diarrhea worldwide.
- Growing awareness about gut health: There is a growing awareness among people about the importance of gut health and its role in overall health and well-being. This is expected to drive the demand for GI stool testing products and services over the next few years.
- Rising prevalence of food allergies: The prevalence of food allergies is rising globally due to changing dietary habits and lifestyles. This is likely to spur demand for GI stool testing products that can help identify food allergens responsible for causing allergic reactions in patients..
Scope Of The Report
Report Attributes
Report Details
Report Title
GI Stool Testing Market Research Report
By Type
Microscopy Tests, Ova & Parasites Test, Occult Blood Test, Stool Biomarkers Tests, Others
By Application
Hospitals, Diagnostics Centers and Laboratories, Research Centers and Academic Institutions
By Companies
Clinical Genomics, Diasorin, Meridian Bioscience, Quidel, bioMerieux, Cenogenics, EIKEN CHEMICAL, Helena Laboratories, Hemosure, Mobidiag, Orion Diagnostica, Pinnacle BioLabs, Polymedco, ScheBo Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global GI Stool Testing Market Report Segments:
The global GI Stool Testing market is segmented on the basis of:
Types
Microscopy Tests, Ova & Parasites Test, Occult Blood Test, Stool Biomarkers Tests, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostics Centers and Laboratories, Research Centers and Academic Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Clinical Genomics
- Diasorin
- Meridian Bioscience
- Quidel
- bioMerieux
- Cenogenics
- EIKEN CHEMICAL
- Helena Laboratories
- Hemosure
- Mobidiag
- Orion Diagnostica
- Pinnacle BioLabs
- Polymedco
- ScheBo Biotech
Highlights of The GI Stool Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microscopy Tests
- Ova & Parasites Test
- Occult Blood Test
- Stool Biomarkers Tests
- Others
- By Application:
- Hospitals
- Diagnostics Centers and Laboratories
- Research Centers and Academic Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GI Stool Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GI stool testing is a procedure that can be used to diagnose gastrointestinal (GI) problems. The test involves collecting samples of feces from the person who is being tested and sending them to a laboratory for analysis. The results of the test can help determine whether the person has a problem with their GI system, such as an infection, inflammation, or digestive issues.
Some of the major companies in the gi stool testing market are Clinical Genomics, Diasorin, Meridian Bioscience, Quidel, bioMerieux, Cenogenics, EIKEN CHEMICAL, Helena Laboratories, Hemosure, Mobidiag, Orion Diagnostica, Pinnacle BioLabs, Polymedco, ScheBo Biotech.
The gi stool testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 GI Stool Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 GI Stool Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 GI Stool Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the GI Stool Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global GI Stool Testing Market Size & Forecast, 2018-2028
4.5.1 GI Stool Testing Market Size and Y-o-Y Growth
4.5.2 GI Stool Testing Market Absolute $ Opportunity
Chapter 5 Global GI Stool Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 GI Stool Testing Market Size Forecast by Type
5.2.1 Microscopy Tests
5.2.2 Ova & Parasites Test
5.2.3 Occult Blood Test
5.2.4 Stool Biomarkers Tests
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global GI Stool Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 GI Stool Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostics Centers and Laboratories
6.2.3 Research Centers and Academic Institutions
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global GI Stool Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 GI Stool Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America GI Stool Testing Analysis and Forecast
9.1 Introduction
9.2 North America GI Stool Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America GI Stool Testing Market Size Forecast by Type
9.6.1 Microscopy Tests
9.6.2 Ova & Parasites Test
9.6.3 Occult Blood Test
9.6.4 Stool Biomarkers Tests
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America GI Stool Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostics Centers and Laboratories
9.10.3 Research Centers and Academic Institutions
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe GI Stool Testing Analysis and Forecast
10.1 Introduction
10.2 Europe GI Stool Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe GI Stool Testing Market Size Forecast by Type
10.6.1 Microscopy Tests
10.6.2 Ova & Parasites Test
10.6.3 Occult Blood Test
10.6.4 Stool Biomarkers Tests
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe GI Stool Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostics Centers and Laboratories
10.10.3 Research Centers and Academic Institutions
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific GI Stool Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific GI Stool Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific GI Stool Testing Market Size Forecast by Type
11.6.1 Microscopy Tests
11.6.2 Ova & Parasites Test
11.6.3 Occult Blood Test
11.6.4 Stool Biomarkers Tests
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific GI Stool Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostics Centers and Laboratories
11.10.3 Research Centers and Academic Institutions
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America GI Stool Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America GI Stool Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America GI Stool Testing Market Size Forecast by Type
12.6.1 Microscopy Tests
12.6.2 Ova & Parasites Test
12.6.3 Occult Blood Test
12.6.4 Stool Biomarkers Tests
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America GI Stool Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostics Centers and Laboratories
12.10.3 Research Centers and Academic Institutions
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) GI Stool Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) GI Stool Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) GI Stool Testing Market Size Forecast by Type
13.6.1 Microscopy Tests
13.6.2 Ova & Parasites Test
13.6.3 Occult Blood Test
13.6.4 Stool Biomarkers Tests
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) GI Stool Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostics Centers and Laboratories
13.10.3 Research Centers and Academic Institutions
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 GI Stool Testing Market: Competitive Dashboard
14.2 Global GI Stool Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Clinical Genomics
14.3.2 Diasorin
14.3.3 Meridian Bioscience
14.3.4 Quidel
14.3.5 bioMerieux
14.3.6 Cenogenics
14.3.7 EIKEN CHEMICAL
14.3.8 Helena Laboratories
14.3.9 Hemosure
14.3.10 Mobidiag
14.3.11 Orion Diagnostica
14.3.12 Pinnacle BioLabs
14.3.13 Polymedco
14.3.14 ScheBo Biotech
